Zdrowie i gospodarka · 20/03/2019

FDA Releases Final Guidance for Pre-Exposure Prophylaxis of HIV-1 Infection

The US Food and Drug Administration (FDA) has released a final guidance document for the pharmaceutical industry, outlining recommendations for developing systemic drug products to prevent HIV-1 infection. The guidance incorporates feedback from industry sponsors and finalizes a draft document released in June 2018.